2nd Annual Microbiome: Translating into Diagnostics and Therapeutics Summit
02-03

October 2018

Austria

Vienna

Hilton Garden Inn Vienna South

Hertha-Firnberg-Straße 5, 1100

About

We are pleased to invite you to the 2nd Annual Microbiome: Translating into Diagnostics and Therapeutics Summit scheduled for October 2nd-3rd, 2018 in Vienna, Austria. This premier B2B event provides you with an appropriate platform to engage with and discuss ideas with your fellow peers while facilitating a professional atmosphere and environment for excellent company representation and development. The Summit will shed light on current challenges, best practices, and inside views of the future of Microbiome in relation to precision medicine...

We are pleased to invite you to the 2nd Annual Microbiome: Translating into Diagnostics and Therapeutics Summit scheduled for October 2nd-3rd, 2018 in Vienna, Austria. This premier B2B event provides you with an appropriate platform to engage with and discuss ideas with your fellow peers while facilitating a professional atmosphere and environment for excellent company representation and development. The Summit will shed light on current challenges, best practices, and inside views of the future of Microbiome in relation to precision medicine. We will discuss key findings, critical insights, and recommendations for driving efficient strategies within the Microbiome landscape. It is an honour and privilege to invite you to participate in this Summit. We look forward to welcoming you in Vienna in October!

more info
Who Should Attend

Chief Executives, Directors, Vice Presidents, Department Heads, Leaders, and Managers specialising in:

  • Microbiome/Microbiota
  • Microbiology
  • Computational biology
  • Autoimmune Disease
  • Infectious Diseases
  • Inflammation
  • Food/Nutrition Science
  • Genotyping
  • Biomarkers
  • Data Management
  • Metagenomics
  • High-Throughput Screening
  • Diagnostic & Clinical Applications
  • Licensing or Technology Transfer
  • Regulatory
  • Clinical trials
  • Bacteria / Fungi / Viruses
  • Molecular Biology
  • Molecular Diagnostics
  • Immuno-oncology
  • Metabolic Disease
  • Vaccines
  • Neurodegeneration / Gut-Brain Axis
  • Genomics
  • Bioinformatics
  • Epigenetics
  • NGS
  • Personalized / Targeted Therapeutics
  • Venture Capitalists
  • Business Development/In-Licensing
  • Market Access
Key Practical Learning Points of the Summit

Emerging science and technologies for successful Microbiome discovery and translation
Commercialization and investment perspectives of Microbiome – based diagnostics and therapeutics
Clinical applications of Microbiome in oncology & beyond
Regulatory compliance for Microbiome drugs
Translation of Microbiome products:
Into clinical trials
For healthy nutrition
Into personalized therapeutics and diagnostic
Speakers
Dr. Barbara Joyce-Shaikh, US

Project Leader, Discovery Research

Merck Research Laboratories

Dr. Oliver Chao, FR

Head, Emerging Biomedical Sciences Strategy & Innovation

Sanofi

Dr. Bram Vanparys, NL

Investment Director, Healthcare

Merck Ventures B.V

Dr. Jesús Zurdo, UK

Sr Director Strategic Innovation Future Technologies

Lonza Biologics plc

Dr. Frédéric Baribaud, US

Scientific Director

Janssen R&D

Dr. Nicholas Monsul, US

CEO & Co-Founder

Quorum Innovations, LLC

Dr. Olga Sakwinska, CH

Research Scientist, Host Microbe Interaction Group / Institute of Nutritional Science Nestec Ltd.

Nestlé Research Center

Dr. Colette Shortt, UK

Consumer Fellow, Regulatory Director

J&J Consumer

Dr. Audrey Gueniche, FR

Clinical Scientific Coordinator / Senior Expert, Advanced Research

L’Oréal Research & Innovation

Dr. Patrice Garnier, FR

Chief Executive Officer

Amabiotics

Dr. Jean de Gunzburg, UK

Chief Scientific Officer

Da Volterra

Dr. Gregory Lambert, FR

CEO – VP R&D

TargEDys SA

Dr. Shahram Lavasani, SE

Founder & CEO

ImmuneBiotech AB

Dr. Imke Mulder, UK

Research Director

4D Pharma Research Ltd.

Annual

Events

Sponsors and Partners

Media partner

Media partner

Media partner

Media partner

Media partner

Media partner

Media partner

Media partner

Media partner

Media partner

Media partner